Living Cell Technologies to reveal clinical trial results
Share
00:30 15 Jun 2015
http://www.*.co.uk/thumbs/upload/News/Image/2016_09/757z468_au_drug_research_350_557e03c35fa6e.jpg
Biotechnology Living Cell Technologies (ASX:LCT) is preparing to divulge clinical trial results.
The company's lead product NTCELL® is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells.
NTCELL is in Phase I/IIa clinical trial in New Zealand as an advanced therapy for the treatment of Parkinson’s disease.
The ASX has granted the company a trading halt to organise, with the company's shares placed in pre-open.
The halt will remain in place until the opening of trade on Tuesday 16th June 2015, or earlier if an announcement is made to the market.
Living Cell is well-funded with $6.3 million in cash at the end of March 2015.
Previous Release.
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $6.268K | 895.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4707556 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1255620 | 12 |
View Market Depth
| Last trade - 15.50pm 12/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |